- Fee assured
- Awaiting verification
- Upper GI
Areas of interest
Thoracic cancer (Lung cancer, Mesothelioma, Thymoma), Upper gastro-intestinal cancer (Oesophageal, Stomach, Pancreas cancer), Gastro intestinal stromal tumour (GIST).
Current NHS consultant posts held
Consultant Clinical Oncologist
Royal Shrewsbury Hospital
Lung cancer and Upper GI cancer phase 3 Clinical Trials.
Principle Investigator for COG, TransCOG, GEM-EORTC, Galaxy2 trial.
Co investigator for ESPAC4, LungCast, Chopin trial.
Clinical Excellance award level1, level 2
English, Bengali, Hindi
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Original TextSusan J Dutton MSc a , Prof David R Ferry PhD b c, Prof Jane M Blazeby MD d e, Haider Abbas MRCP b, Asa Dahle-Smith MBChB f, Wasat Mansoor PhD g, Joyce Thompson FRCP h, Mark Harrison PhD i, Anirban Chatterjee FRCR j, Stephen Falk MD d, Angel Garcia-Alonso MD k, David W Fyfe MD l, Richard A Hubner PhD g, Tina Gamble h, Lynnda Peachey BSc m, Mina Davoudianfar BA m, Sarah R Pearson BSc m, Patrick Julier MSc m, Prof Janusz Jankowski PhD n, Rachel Kerr MD m, Russell D Petty MRCP
The Lancet Oncology, Volume 15, Issue 8, Pages 894 - 904, July 2014
- FRCR Royal College of Radiologists 2005
- MRCP Royal College of Physicians 2001
- Post Graduate Diploma in Oncology University of Nottingham 2004
- MBBS University of Calcutta 1994
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (1-5)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)